Shintaro Fukushima

Model Change Detection With the MDL Principle

Kenji Yamanishi, Shintaro Fukushima, K. Yamanishi, 2018, IEEE Transactions on Information Theory.

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases

Seiya Kato, Yasuo Sugita, Shintaro Fukushima, 2009, Brain Tumor Pathology.

IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy.

Minako Sumi, Yoshiko Okita, Yoshitaka Narita, 2012, International journal of oncology.

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors

Naoki Kagawa, Akihiko Yoshida, Shuichi Izumoto, 2018, Acta Neuropathologica Communications.